Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Change in Inventory (2019 - 2026)

Akebia Therapeutics has reported Change in Inventory over the past 7 years, most recently at $17.4 million for Q4 2025.

  • Quarterly Change in Inventory rose 105.01% to $17.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.1 million through Dec 2025, down 18.58% year-over-year, with the annual reading at $23.1 million for FY2025, 18.58% down from the prior year.
  • Change in Inventory was $17.4 million for Q4 2025 at Akebia Therapeutics, up from -$6.9 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $19.2 million in Q1 2021 and troughed at -$24.5 million in Q4 2022.
  • The 5-year median for Change in Inventory is $3.0 million (2023), against an average of $3.0 million.
  • The largest YoY upside for Change in Inventory was 765.2% in 2021 against a maximum downside of 4201.19% in 2021.
  • A 5-year view of Change in Inventory shows it stood at -$10.3 million in 2021, then crashed by 136.59% to -$24.5 million in 2022, then soared by 148.18% to $11.8 million in 2023, then decreased by 27.88% to $8.5 million in 2024, then skyrocketed by 105.01% to $17.4 million in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Change in Inventory are $17.4 million (Q4 2025), -$6.9 million (Q3 2025), and $7.7 million (Q2 2025).